Description
Glutax 2000000gx Dualna Premium Recombined Cell – 10 Sessions
Introducing the enhanced Glutax 2000000gx Premium Recombined Cell: Now fortified with additional vitamins for superior skin restoration and faster results. This product is ideal for skin lightening, offering proven efficacy and improved formulation with added Anti-Aging elements.
Benefits
Benefits of Glutax 2000000gx Dualna Premium Recombined Cell:
Luminous Skin: Achieves glowing, silky smooth skin by reducing melanin production.
Anti-Aging: Reduces visible signs of aging like fine lines and wrinkles, enhancing skin elasticity.
Skin Clarity: Diminishes the appearance of scars, enlarged pores, and pigmentation caused by sun exposure.
Acne and Blemish Control: Helps in preventing the occurrence of acne, blemishes, and pimples, promoting clear skin.
Antioxidant Protection: Neutralizes harmful free radicals, protecting the skin from environmental stressors.
Ingredients
DNA & RNA Multivitamins: 25000mg
– DNA & RNA Natural Collagen: 12000mg
– DNA & RNA Selenium: 5000mg
– DNA & RNA Glutathione: 2000000g
– DNA & RNA Ultra White Elements: 6000mg
– DNA & RNA Epidermal Growth Factor: 8000mg
– DNA & RNA ProEnzyme Q10: 3700mg
– DNA & RNA PDRN Hyal: 4800mg
Packaging: The product comes in boxes containing 10 sets each.
Usage
Combine one set with a Spuit injection. For optimal results, inject once per week, with maintenance follow-ups every 2 weeks or once a month. Regular injections will accelerate the skin whitening process, leading to vibrant, beautifully white skin with outstanding results.
Check Out The Best Glutathione Injections
Dr James Glutathione Injection 1500mg Skin Whitening Injection
Vesco Pharma Gluta C 1000 Glutathione Injection
Check Out Other Injections
Collagen Injection By Vesco Pharma Collagen C 1000
Vitamin C Injection By Vesco Pharma VC Vitamin C 1000mg
Vesco Pharma Placenta C Injection Placenta Extract Injection
Vesco Pharma Glutathione Booster Injection
Nexus Pharma Liponex 300 Thioctic Acid Injection








Reviews
There are no reviews yet.